Life Venture Industry Talent Summit 2020 (LIT2020) Registration Now Open: A Premier, High-Efficiency Gathering for Health Innovation Leaders

November 26–27, the 2020 Life Venture Industry Talent Summit (LIT2020) will be grandly held in Shanghai.

Over the past three years, the Life Capital Investment and Financing Summit has stood out among numerous healthcare conferences for its high-end, efficient, and exclusive format. With an annual cap of 50 founders and investors per sector, seats are in exceptionally high demand.

2020 was a remarkable year in which we witnessed many historical moments worth remembering. Unprecedented opportunities and challenges emerged in the medical field, heralding the dawn of a new era. In this new era, Life Capital firmly believes that academia, industry, and capital will integrate more closely. Through sustained, high-frequency interaction between industry and capital, new opportunities will arise in the healthcare and life sciences sectors.

Based on this assessment, Life Capital is upgrading its “Investment and Financing Summit” to the “Industrial Capital Summit” this year. While continuing to focus on three key sectors—innovative drugs, medical devices, and smart healthcare plus health insurance—the composition of attendees will be further optimized. The number of seats per sub-forum has been reduced from the previous format of 50 founders and 50 investors (100 total) to just 90 seats. These 90 seats will be allocated among three groups—founders, investors, and executives of listed companies along with industry leaders—to strengthen interaction between founders, investors, and the broader industry.

Limited spots available

Please scan the QR code below immediately.

Real-name Verification Registration

Life Capital is China’s leading financial services institution focused on the broader health sector. Its business lines encompass investment banking and venture capital, with a commitment to cultivating future industry leaders in the health sector.

Team members hail from renowned investment banks, academic institutions, and healthcare companies, bringing decades of accumulated expertise in the healthcare and investment financing sectors.

Over the past three years, the team has completed dozens of financing and M&A transactions in the healthcare industry, with a cumulative value of nearly RMB 10 billion. These deals span various sub-sectors, including new drug R&D, medical devices, diagnostics, healthcare services, smart healthcare, health insurance, agricultural technology, and food technology.In the 2020 China Financial Advisory Firm Rankings hosted by Qiming Technology, a renowned financial big data institution, Life Capital was selected as one of the Top 3 financial advisory firms in the Chinese healthcare sector.